New Delhi: India’s Ranbaxy Laboratories, which has got orders from the national government to supply the generic version of Roche’s anti-viral Tamiflu, used to treat the H1N1 flu, will supply 900,000 capsules initially, a spokesman told Reuters on Wednesday.
Ranbaxy is majority owned by Japan’s Daiichi Sankyo.